Advanced Emissions Solutions to Present at Environmental 14-03-2023, 04:42

Nasdaq Stockholm Streamlines Dual Listing Process for US-Listed Companies to access European markets 2-12-2024, 21:00

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma 16-10-2023, 19:21